{"id":28849,"date":"2017-03-30T17:31:54","date_gmt":"2017-03-30T15:31:54","guid":{"rendered":"http:\/\/blog.cofb.cat\/?p=28849"},"modified":"2017-03-30T17:31:54","modified_gmt":"2017-03-30T15:31:54","slug":"infarma-guia-de-problemes-de-pell-resistencia-als-antibiotics-temes-destacats-als-mitjans-al-febrer","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/ca\/2017\/03\/30\/infarma-guia-de-problemes-de-pell-resistencia-als-antibiotics-temes-destacats-als-mitjans-al-febrer\/","title":{"rendered":"Infarma, guia de problemes de pell i resist\u00e8ncia als antibi\u00f2tics, temes destacats als mitjans al febrer"},"content":{"rendered":"

\u00a0Infarma Barcelona 2017\u00a0<\/strong><\/a><\/p>\n[caption id=\"attachment_28860\" align=\"alignright\" width=\"270\"]\"Infarma,<\/a> Repercussi\u00f3 d’El Global sobre la presentaci\u00f3 del pre-programa d’Infarma[\/caption]\n

Durant el febrer, es va continuar amb l’enviament de notes de premsa (1<\/a> i 2<\/a>) per informar de les novetats d\u2019Infarma. De la primera, en van fer difusi\u00f3 a la premsa especialitzada\u00a0El Global<\/a>, Acta Sanitaria<\/a>, IMFarmacias<\/a>, El Farmac\u00e9utico<\/a>, Diariofarma<\/a>, Farmanatur<\/a>, Farmaventas<\/a> i Sanifax, entre altres. D’unal\u2019altra nota enviada, en van fer ress\u00f2 Diariofarma<\/a>, IMFarmacias<\/a>, Acta Sanitaria<\/a>, Farmaventas<\/a>, Farmanatur<\/a> i Sanifax.<\/p>\n[caption id=\"attachment_28861\" align=\"alignleft\" width=\"216\"]\"Infarma,<\/a> M\u00f2nica Gallach, responsable de Formaci\u00f3 del Departament de Formaci\u00f3 i Desenvolupament Professional del Col\u00b7legi, a IMFarmacias[\/caption]\n

 <\/p>\n

 <\/p>\n

Alhora,\u00a0IMFarmacias<\/a>, va realitzar una entrevista a la responsable de Formaci\u00f3 del Departament de Formaci\u00f3 i Desenvolupament Professional del Col\u00b7legi, M\u00f2nica Gallach, tamb\u00e9 sota el marc d’Infarma, que es va centrar a informar\u00a0cap a on s\u2019estan especialitzant i focalitzant els cursos formatius<\/b>. D\u2019aquesta manera, Gallach va donar el seu parer en\u00a0com estava evolucionant el paper del farmac\u00e8utic i cap a on s\u2019ha d\u2019orientar i formar.<\/b><\/div><\/b><\/p>\n

<\/b>Guia de problemes de pell de baixa complexitat a la farm\u00e0cia<\/b><\/a><\/p>\n[caption id=\"attachment_28862\" align=\"alignright\" width=\"300\"]\"Infarma,<\/a> La Vanguardia informant sobre la guia de problemes de pell de baixa complexitat[\/caption]\n

El mes passat, mitjans de la premsa generalista i de l\u2019especialitzada van informar sobre la presentaci\u00f3 de la guia \u201cAtenci\u00f3 compartida de problemes de la pell de baixa complexitat a la farm\u00e0cia comunit\u00e0ria\u201d<\/b>, un document elaborat per farmac\u00e8utics i metges de fam\u00edlia catalans que persegueix optimitzar l\u2019atenci\u00f3 a pacients que acudeixen a la farm\u00e0cia comunit\u00e0ria amb aquests tipus de demandes<\/b>. La iniciativa ha estat coordinada des del Consell de Col\u00b7legis de Farmac\u00e8utics de Catalunya<\/a> (CCFC) juntament amb el Grup de Dermatologia de la Societat Catalana de Medicina Familiar i Comunit\u00e0ria<\/a> i consisteix en un conjunt de protocols d\u2019actuaci\u00f3 amb el seu corresponent algoritme de decisi\u00f3 que orienta, facilita i homogene\u00eftza l\u2019actuaci\u00f3 en les consultes m\u00e9s freq\u00fcents relacionades amb problemes a la pell<\/strong>. En vam fer difusi\u00f3 mitjan\u00e7ant una nota de premsa<\/a>\u00a0que van recollir La Vanguardia<\/a>, Al Dia<\/a>, Diariofarma<\/a>, Acta Sanitaria<\/a>, IMFarmacias<\/a>, El Farmac\u00e9utico<\/a>, imM\u00e9dico<\/a>,\u00a0Farmaventas<\/a> i Sanifax, entre altres.<\/p>\n

 <\/p>\n[caption id=\"attachment_28863\" align=\"alignleft\" width=\"300\"]\"Infarma,<\/a> Entrevista a Rafael Guayta, director de Projectes i Recerca del Consell, a R\u00e0dio Terrassa[\/caption]\n

Tanmateix, el programa El Submar\u00ed<\/i> de R\u00e0dio Terrassa<\/a> va entrevistar al director de Projectes i Recerca del Consell, Rafael Guayta, per parlar sobre la guia. Durant l\u2019\u00e0udio, Guayta defineix el projecte, com s\u2019ha dut a terme i el paper del farmac\u00e8utic per abordar aquest tipus de problema.<\/p>\n

 <\/p>\n

<\/div><\/b><\/p>\n

<\/b>Resist\u00e8ncia dels antibi\u00f2tics<\/b><\/p>\n[caption id=\"attachment_28884\" align=\"alignright\" width=\"300\"]\"3DF\"<\/a> Diariofarma va explicar el comunicat que es va realitzar des del COFB[\/caption]\n

A mitjans de febrer el Col\u00b7legi va emetre un comunicat<\/a> on es va incidir sobre la import\u00e0ncia de seguir correctament els tractaments antibi\u00f2tics<\/b>, tot coincidint amb diverses not\u00edcies que van esdevenir-se durant el mes. A causa d’aquestes informacions, el programa El m\u00f3n a RAC1<\/i><\/a> va prendre declaracions de Guillermo Bagar\u00eda, vicetresorer del Col\u00b7legi, en les quals va assegurar la responsabilitat del farmac\u00e8utic a l\u2019hora de dispensar aquest tipus de f\u00e0rmac\u00a0<\/b>(tall de les 8 a les 9h, del minut 15’50” al 20’05” del 10\/02\/2017)\u00a0i, alhora, Diariofarma<\/a>\u00a0va compartir el manifest del COFB en una not\u00edcia on es desglossava el text i s\u2019explicava.<\/div><\/b><\/p>\n

<\/b>Temps d\u2019\u00c9coute<\/em> al Col\u00b7legi<\/b><\/a><\/p>\n[caption id=\"attachment_28865\" align=\"alignleft\" width=\"270\"]\"4IMF\"<\/a> IMFarmacias va explicar la projecci\u00f3 del documental ‘Temps d’\u00c9coute’ al Col\u00b7legi[\/caption]\n

El Col\u00b7legi va acollir, el passat 3 de febrer, la projecci\u00f3 del film Temps d\u2019\u00c9coute<\/em><\/a><\/b>, una pel\u00b7l\u00edcula que va servir perqu\u00e8 metges, infermers, psic\u00f2legs i farmac\u00e8utics reflexionessin sobre g\u00e8nere i salut de la m\u00e0 de Farmamundi<\/a><\/b>. IMFarmacias<\/a>, Diariofarma<\/a>, Farmaventas<\/a> i Sanifax van ser els mitjans que en van fer difusi\u00f3 informant dels diferents objectius de la projecci\u00f3, com apropar als assistents la realitat de la Rep\u00fablica Democr\u00e0tica del Congo<\/b> i, d\u2019aquesta manera, trencar amb el silenci que viuen moltes dones d\u2019aquell pa\u00eds, generar debat i acabar amb possibles estereotips.<\/b><\/p>\n

<\/div><\/b><\/p>\n

Farm\u00e0cia assistencial<\/b><\/p>\n

Tamb\u00e9 el mes passat, els mitjans van recollir diversos temes relacionats amb el rol assistencial que cada cop amb m\u00e9s est\u00e0 adoptant el farmac\u00e8utic comunitari: cooperaci\u00f3 interprofessional, Dia Mundial Contra el C\u00e0ncer i la proposta de llei promoguda per Ciutadans.<\/b><\/p>\n[caption id=\"attachment_28956\" align=\"alignright\" width=\"300\"]\"CF\"<\/a> Cooperaci\u00f3 interprofessional al Correo Farmac\u00e9utico[\/caption]\n

El 13 de febrer, Correo Farmac\u00e9utico<\/a> va publicar una not\u00edcia explicant la col\u00b7laboraci\u00f3 que<\/b>, cada vegada m\u00e9s, s\u2019est\u00e0 establint entre metges i farmac\u00e8utics<\/b> per tal de \u201csumar esfor\u00e7os en benefici del pacient polimedicat\u201d<\/b>, tal com informa el mitj\u00e0. La not\u00edcia destaca diferents serveis amb equips interdisciplinaris que s\u2019han anat realitzat a les farm\u00e0cies de les diferents Comunitats Aut\u00f2nomes i en puntualitza un que es va dur a terme des de Catalunya: la campanya de detecci\u00f3 del pols irregular per prevenir l’ictus<\/a>, Pren-te el pols!<\/i><\/a><\/b>\u00a0Tot i aix\u00f2, en la repercussi\u00f3 tamb\u00e9 es concreta que encara hi ha molt cam\u00ed per rec\u00f3rrer per tal d\u2019aconseguir una plena implicaci\u00f3.<\/p>\n[caption id=\"attachment_28868\" align=\"alignleft\" width=\"240\"]\"5EG\"<\/a> Not\u00edcia a El Global sobre les diferents iniciatives per fer front al c\u00e0ncer[\/caption]\n

D\u2019altra banda, el 4 de febrer va ser el Dia Mundial Contra el C\u00e0ncer<\/a> i, coincidint amb aquesta data, El Global<\/a> va treure una pe\u00e7a informant d\u2019alguns dels projectes que des de la farm\u00e0cia s\u2019estan impulsant<\/b> i que la situen, segons el mitj\u00e0, \u201cen primera l\u00ednia de la lluita contra el c\u00e0ncer\u201d<\/b>. Per tal d\u2019explicar la situaci\u00f3 actual i, alhora, algunes iniciatives, es van prendre declaracions de diferents responsables de diversos COFs d\u2019Espanya, dels quals cal destacar les paraules de Rafael Guayta, director de Projectes i Investigaci\u00f3 del Consell. Guayta va fer una\u00a0an\u00e0lisi de la bona participaci\u00f3 pel que fa al cribratge de c\u00e0ncer de c\u00f2lon<\/b> i, tanmateix, va fer una\u00a0mirada cap al futur<\/b>, promovent \u201cl\u2019aparici\u00f3 de nous elements diagn\u00f2stics i t\u00e8cniques m\u00e9s senzilles\u201d.<\/b><\/p>\n

Finalment, El Global<\/a> i Diariofarma<\/a> van explicar la rebutja per part del Parlament de Catalunya de la Proposici\u00f3 de llei presentada per Ciutadans on s\u2019impulsava el paper de la farm\u00e0cia en coordinaci\u00f3 amb el Sistema Nacional de Salut i, d\u2019aquesta manera, facilitar l\u2019acc\u00e9s a la hist\u00f2ria cl\u00ednica dels pacients. Tots dos mitjans van prendre declaracions de Pilar Gasc\u00f3n, secret\u00e0ria del Consell<\/strong>, va afirmar que \u201ces va corroborar el valor sanitari del farmac\u00e8utic, encara que hagi de concretar-se a trav\u00e9s d\u2019algun altre rang normatiu o instituci\u00f3\u201d.<\/div><\/b><\/b><\/p>\n

Fonts d\u2019informaci\u00f3<\/b><\/p>\n[caption id=\"attachment_28869\" align=\"alignright\" width=\"300\"]\"6LV\"<\/a> La Vanguardia informa sobre el Cercle de Salut[\/caption]\n

Un mes m\u00e9s, el Col\u00b7legi ha servit com a font de refer\u00e8ncia per diferents mitjans de comunicaci\u00f3. En el cas de La Vanguardia<\/a> i Redacci\u00f3n M\u00e9dica<\/a>, es va\u00a0parlar sobre el Cercle de Salut, \u201cel nou f\u00f2rum de debat que promou el debat sobre la millor del sistema de salut\u201d<\/b>, tal com ho defineix La Vanguardia. Tots dos mitjans van fer menci\u00f3 al COFB puntualitzant que, juntament amb altres col\u00b7legis professionals, com el de Metges i Infermeres i Infermers, d\u00f3na suport a la iniciativa.<\/b><\/p>\n

Finalment, d’altres mitjans de la premsa especialitzada\u00a0tamb\u00e9 van servir-se de declaracions de la instituci\u00f3 per complementar tres peces de diferents tem\u00e0tiques: la tos i precaucions en l\u2019autocura a asm\u00e0tics, hipertensos i nens petits<\/a>; limitaci\u00f3 d\u2019algunes necessitats dels diab\u00e8tics -com les tires reactives de glucosa o els absorbents d\u2019incontin\u00e8ncia orinaria-<\/a>\u00a0<\/b>(ambdues a Correo Farmac\u00e9utico); i, finalment, col\u00b7lagen i espor<\/a><\/b>t<\/a>\u00a0<\/strong>(Consejos de tu farmac\u00e9utico).<\/div><\/b><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":28970,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[23,32],"tags":[2689,2724,2725,113,235,2726,2491,459,2582,2727,35,2625],"class_list":["post-28849","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-destacats","category-noticies-farmacia","tag-cercle-de-salut","tag-cooperacio-interprofessional","tag-dia-mundiaal-contra-el-cancer","tag-farmacia-assistencial","tag-farmamundi","tag-guia-de-pell-de-baixa-complexitat","tag-infarma-barcelona-2017","tag-mitjans","tag-pren-te-el-pols","tag-proposta-de-llei-ciutadans","tag-resistencia-antibiotics","tag-temps-decoute"],"yoast_head":"\nInfarma, guia de problemes de pell i resist\u00e8ncia als antibi\u00f2tics, temes destacats als mitjans al febrer<\/title>\n<meta name=\"description\" content=\"Infarma, guia de problemes de pell i resist\u00e8ncia als antibi\u00f2tics, temes destacats als mitjans al febrer\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2017\/03\/30\/infarma-guia-de-problemes-de-pell-resistencia-als-antibiotics-temes-destacats-als-mitjans-al-febrer\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Infarma, guia de problemes de pell i resist\u00e8ncia als antibi\u00f2tics, temes destacats als mitjans al febrer\" \/>\n<meta property=\"og:description\" content=\"Infarma, guia de problemes de pell i resist\u00e8ncia als antibi\u00f2tics, temes destacats als mitjans al febrer\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2017\/03\/30\/infarma-guia-de-problemes-de-pell-resistencia-als-antibiotics-temes-destacats-als-mitjans-al-febrer\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2017-03-30T15:31:54+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/03\/30\/infarma-guia-de-problemes-de-pell-resistencia-als-antibiotics-temes-destacats-als-mitjans-al-febrer\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/03\/30\/infarma-guia-de-problemes-de-pell-resistencia-als-antibiotics-temes-destacats-als-mitjans-al-febrer\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Infarma, guia de problemes de pell i resist\u00e8ncia als antibi\u00f2tics, temes destacats als mitjans al febrer\",\"datePublished\":\"2017-03-30T15:31:54+00:00\",\"dateModified\":\"2017-03-30T15:31:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/03\/30\/infarma-guia-de-problemes-de-pell-resistencia-als-antibiotics-temes-destacats-als-mitjans-al-febrer\/\"},\"wordCount\":1391,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/03\/30\/infarma-guia-de-problemes-de-pell-resistencia-als-antibiotics-temes-destacats-als-mitjans-al-febrer\/#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"cercle de salut\",\"cooperaci\u00f3 interprofessional\",\"Dia Mundiaal Contra el C\u00e0ncer\",\"farm\u00e0cia assistencial\",\"Farmamundi\",\"Guia de pell de baixa complexitat\",\"Infarma Barcelona 2017\",\"Mitjans\",\"pren-te el pols\",\"Proposta de llei Ciutadans\",\"Resist\u00e8ncia antibi\u00f2tics\",\"Temps d\u2019\u00c9coute\"],\"articleSection\":[\"Destacats\",\"Not\u00edcies farm\u00e0cia\"],\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2017\/03\/30\/infarma-guia-de-problemes-de-pell-resistencia-als-antibiotics-temes-destacats-als-mitjans-al-febrer\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/03\/30\/infarma-guia-de-problemes-de-pell-resistencia-als-antibiotics-temes-destacats-als-mitjans-al-febrer\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2017\/03\/30\/infarma-guia-de-problemes-de-pell-resistencia-als-antibiotics-temes-destacats-als-mitjans-al-febrer\/\",\"name\":\"Infarma, guia de problemes de pell i resist\u00e8ncia als antibi\u00f2tics, temes destacats als mitjans al febrer\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/03\/30\/infarma-guia-de-problemes-de-pell-resistencia-als-antibiotics-temes-destacats-als-mitjans-al-febrer\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/03\/30\/infarma-guia-de-problemes-de-pell-resistencia-als-antibiotics-temes-destacats-als-mitjans-al-febrer\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2017-03-30T15:31:54+00:00\",\"dateModified\":\"2017-03-30T15:31:54+00:00\",\"description\":\"Infarma, guia de problemes de pell i resist\u00e8ncia als antibi\u00f2tics, temes destacats als mitjans al febrer\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/03\/30\/infarma-guia-de-problemes-de-pell-resistencia-als-antibiotics-temes-destacats-als-mitjans-al-febrer\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2017\/03\/30\/infarma-guia-de-problemes-de-pell-resistencia-als-antibiotics-temes-destacats-als-mitjans-al-febrer\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/03\/30\/infarma-guia-de-problemes-de-pell-resistencia-als-antibiotics-temes-destacats-als-mitjans-al-febrer\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/03\/30\/infarma-guia-de-problemes-de-pell-resistencia-als-antibiotics-temes-destacats-als-mitjans-al-febrer\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Infarma, guia de problemes de pell i resist\u00e8ncia als antibi\u00f2tics, temes destacats als mitjans al febrer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Infarma, guia de problemes de pell i resist\u00e8ncia als antibi\u00f2tics, temes destacats als mitjans al febrer","description":"Infarma, guia de problemes de pell i resist\u00e8ncia als antibi\u00f2tics, temes destacats als mitjans al febrer","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2017\/03\/30\/infarma-guia-de-problemes-de-pell-resistencia-als-antibiotics-temes-destacats-als-mitjans-al-febrer\/","og_locale":"ca_ES","og_type":"article","og_title":"Infarma, guia de problemes de pell i resist\u00e8ncia als antibi\u00f2tics, temes destacats als mitjans al febrer","og_description":"Infarma, guia de problemes de pell i resist\u00e8ncia als antibi\u00f2tics, temes destacats als mitjans al febrer","og_url":"https:\/\/novaorg.cofb.net\/2017\/03\/30\/infarma-guia-de-problemes-de-pell-resistencia-als-antibiotics-temes-destacats-als-mitjans-al-febrer\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2017-03-30T15:31:54+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrit per":"wpAdminCofbOrg","Temps estimat de lectura":"7 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2017\/03\/30\/infarma-guia-de-problemes-de-pell-resistencia-als-antibiotics-temes-destacats-als-mitjans-al-febrer\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2017\/03\/30\/infarma-guia-de-problemes-de-pell-resistencia-als-antibiotics-temes-destacats-als-mitjans-al-febrer\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Infarma, guia de problemes de pell i resist\u00e8ncia als antibi\u00f2tics, temes destacats als mitjans al febrer","datePublished":"2017-03-30T15:31:54+00:00","dateModified":"2017-03-30T15:31:54+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2017\/03\/30\/infarma-guia-de-problemes-de-pell-resistencia-als-antibiotics-temes-destacats-als-mitjans-al-febrer\/"},"wordCount":1391,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2017\/03\/30\/infarma-guia-de-problemes-de-pell-resistencia-als-antibiotics-temes-destacats-als-mitjans-al-febrer\/#primaryimage"},"thumbnailUrl":"","keywords":["cercle de salut","cooperaci\u00f3 interprofessional","Dia Mundiaal Contra el C\u00e0ncer","farm\u00e0cia assistencial","Farmamundi","Guia de pell de baixa complexitat","Infarma Barcelona 2017","Mitjans","pren-te el pols","Proposta de llei Ciutadans","Resist\u00e8ncia antibi\u00f2tics","Temps d\u2019\u00c9coute"],"articleSection":["Destacats","Not\u00edcies farm\u00e0cia"],"inLanguage":"ca","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2017\/03\/30\/infarma-guia-de-problemes-de-pell-resistencia-als-antibiotics-temes-destacats-als-mitjans-al-febrer\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2017\/03\/30\/infarma-guia-de-problemes-de-pell-resistencia-als-antibiotics-temes-destacats-als-mitjans-al-febrer\/","url":"https:\/\/novaorg.cofb.net\/2017\/03\/30\/infarma-guia-de-problemes-de-pell-resistencia-als-antibiotics-temes-destacats-als-mitjans-al-febrer\/","name":"Infarma, guia de problemes de pell i resist\u00e8ncia als antibi\u00f2tics, temes destacats als mitjans al febrer","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2017\/03\/30\/infarma-guia-de-problemes-de-pell-resistencia-als-antibiotics-temes-destacats-als-mitjans-al-febrer\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2017\/03\/30\/infarma-guia-de-problemes-de-pell-resistencia-als-antibiotics-temes-destacats-als-mitjans-al-febrer\/#primaryimage"},"thumbnailUrl":"","datePublished":"2017-03-30T15:31:54+00:00","dateModified":"2017-03-30T15:31:54+00:00","description":"Infarma, guia de problemes de pell i resist\u00e8ncia als antibi\u00f2tics, temes destacats als mitjans al febrer","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2017\/03\/30\/infarma-guia-de-problemes-de-pell-resistencia-als-antibiotics-temes-destacats-als-mitjans-al-febrer\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2017\/03\/30\/infarma-guia-de-problemes-de-pell-resistencia-als-antibiotics-temes-destacats-als-mitjans-al-febrer\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/novaorg.cofb.net\/2017\/03\/30\/infarma-guia-de-problemes-de-pell-resistencia-als-antibiotics-temes-destacats-als-mitjans-al-febrer\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2017\/03\/30\/infarma-guia-de-problemes-de-pell-resistencia-als-antibiotics-temes-destacats-als-mitjans-al-febrer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Infarma, guia de problemes de pell i resist\u00e8ncia als antibi\u00f2tics, temes destacats als mitjans al febrer"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":null,"_links":{"self":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/28849","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/comments?post=28849"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/28849\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media?parent=28849"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/categories?post=28849"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/tags?post=28849"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}